◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Eisai Co., Ltd. (4523) Financial History

Name: Eisai Co., Ltd. (4523) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Eisai Co., Ltd. (4523) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 10,543 employees. Its market capitalization is roughly JPY 1.40 trillion. In the fiscal year ended 2026-03-31, 4523 reported JPY 825.4B in revenue and JPY 38.6B in net income.

Eisai Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals in Japan. The company operates through pharmaceuticals business and other business segments.

Interactive charts & full statements →

4523 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 825.4B	JPY 789.4B	JPY 741.8B	JPY 744.4B
Gross Profit	JPY 634.2B	JPY 620.6B	JPY 586.4B	JPY 566.6B
Operating Income (EBIT)	JPY 44.1B	JPY 54.4B	JPY 53.4B	JPY 40.0B
Net Income	JPY 38.6B	JPY 46.4B	JPY 42.4B	JPY 55.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4523 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 45.1B)	(JPY 45.5B)	(JPY 45.9B)	(JPY 45.9B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4523 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 1.45T	JPY 1.39T	JPY 1.39T	JPY 1.26T
Total Liabilities	JPY 524.0B	JPY 520.6B	JPY 494.8B	JPY 440.8B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4523 viewer.

4523 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4502 · Takeda Pharmaceutical Company Limited — $8.91 trillion
4507 · Shionogi & Co., Ltd. — $2.42 trillion
4151 · Kyowa Kirin Co., Ltd. — $1.34 trillion
4506 · Sumitomo Pharma Co., Ltd. — $603 billion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4521 All “0-9” companies 4524 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.